Back to Search Start Over

Spatial Positioning and Matrix Programs of Cancer-Associated Fibroblasts Promote T-cell Exclusion in Human Lung Tumors.

Authors :
Grout JA
Sirven P
Leader AM
Maskey S
Hector E
Puisieux I
Steffan F
Cheng E
Tung N
Maurin M
Vaineau R
Karpf L
Plaud M
Begue AL
Ganesh K
Mesple J
Casanova-Acebes M
Tabachnikova A
Keerthivasan S
Lansky A
Berichel JL
Walker L
Rahman AH
Gnjatic S
Girard N
Lefevre M
Damotte D
Adam J
Martin JC
Wolf A
Flores RM
Beasley MB
Pradhan R
Muller S
Marron TU
Turley SJ
Merad M
Kenigsberg E
Salmon H
Source :
Cancer discovery [Cancer Discov] 2022 Nov 02; Vol. 12 (11), pp. 2606-2625.
Publication Year :
2022

Abstract

It is currently accepted that cancer-associated fibroblasts (CAF) participate in T-cell exclusion from tumor nests. To unbiasedly test this, we used single-cell RNA sequencing coupled with multiplex imaging on a large cohort of lung tumors. We identified four main CAF populations, two of which are associated with T-cell exclusion: (i) MYH11+αSMA+ CAF, which are present in early-stage tumors and form a single cell layer lining cancer aggregates, and (ii) FAP+αSMA+ CAF, which appear in more advanced tumors and organize in patches within the stroma or in multiple layers around tumor nests. Both populations orchestrate a particular structural tissue organization through dense and aligned fiber deposition compared with T cell-permissive CAF. Yet they produce distinct matrix molecules, including collagen IV (MYH11+αSMA+ CAF) and collagen XI/XII (FAP+αSMA+ CAF). Hereby, we uncovered unique molecular programs of CAF driving T-cell marginalization, whose targeting should increase immunotherapy efficacy in patients bearing T cell-excluded tumors.<br />Significance: The cellular and molecular programs driving T-cell marginalization in solid tumors remain unclear. Here, we describe two CAF populations associated with T-cell exclusion in human lung tumors. We demonstrate the importance of pairing molecular and spatial analysis of the tumor microenvironment, a prerequisite to developing new strategies targeting T cell-excluding CAF. See related commentary by Sherman, p. 2501. This article is highlighted in the In This Issue feature, p. 2483.<br /> (©2022 American Association for Cancer Research.)

Details

Language :
English
ISSN :
2159-8290
Volume :
12
Issue :
11
Database :
MEDLINE
Journal :
Cancer discovery
Publication Type :
Academic Journal
Accession number :
36027053
Full Text :
https://doi.org/10.1158/2159-8290.CD-21-1714